The UnitedHealth Group’s proposed acquisition of EMIS, a healthcare technology firm, was approved by the Competition and Markets Authority in the UK. Aby Jose Koilparambil, a Reuters reporter, said. “Britain’s competition regulator has provisionally cleared UnitedHealth Group’s acquisition of healthcare technology firm EMIS.” Eva Mathews, also with Reuters, adds “The Competition and Markets Authority found no competition concerns in the deal between specialist health care tech and software companies.”
The offer to acquire EMIS was made by Optum UK, a subsidiary of UnitedHealth, in June last year. The CMA launched its initial merger enquiry in January and referred the deal to a deeper probe in March. However, after a thorough investigation, the CMA found that no competition concerns are present in the deal, allowing for the acquisition to be approved.
Related: UK Watchdog Says UnitedHealth Takeover Of EMIS Could Hurt National Health Service
Together, Optum UK and EMIS will work to create a more innovative healthcare sector. UnitedHealth Group commented on the deal as a “strong bridge between the skills, innovations and networks of both companies”. With the approval of the CMA, both companies are now able to pursue their mission to bring high quality healthcare to people across the UK.
Source: Saltwire
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI